Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells.
Vecchio E, Marino R, Mimmi S, Canale C, Caiazza C, Arcucci A, Ruocco MR, Schiavone M, Santamaria G, Palmieri C, Iaccino E, Mallardo M, Quinto I, Fiume G.
Vecchio E, et al. Among authors: santamaria g.
Front Oncol. 2024 Feb 2;14:1339584. doi: 10.3389/fonc.2024.1339584. eCollection 2024.
Front Oncol. 2024.
PMID: 38371626
Free PMC article.